C57BL/6N-Tg(Vav1-BCL2L1)670Biat/Biat

Status

Available to order

EMMA IDEM:11778
Citation informationRRID:IMSR_EM:11778 

Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information.

International strain nameC57BL/6N-Tg(Vav1-BCL2L1)670Biat/Biat
Alternative nameC57BL/6N-Tg(Vav-BCLX)670Biat, or Vav-BCLX
Strain typeTransgenic Strains
Allele/Transgene symbolTg(Vav1-BCL2L1)670Biat
Gene/Transgene symbolTg(Vav1-BCL2L1)670Biat

Information from provider

ProviderAndreas Villunger
Provider affiliationDivision of Developmental Immunology, Medical University Innsbruck
Genetic informationRandom transgene insertion of human FLAG-BCLX cDNA into C57BL/6N oocytes; Vav-BCLX TG mice were generated by pronuclear injection of the VavP vectors [Ogilvy 1999 see reference below] encoding human FLAG-BCLX (BCL2L1) cDNA into C57BL/6N oocytes. The founder lines were designated as C57BL/6N-Tg(Vav-BCLX)670, 671, 672Biat, or Vav-BCLX TG line A, B, C. Only C57BL/6N-Tg(Vav-BCLX)670Biat (Vav-BCLX TG line A) is submitted. REFERENCE: Ogilvy, S., Metcalf, D., Gibson, L., Bath, M. L., Harris, A. W. & Adams, J. M. (1999) Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment, Blood. 94, 1855-1863.
Phenotypic informationHomozygous:
NA

Heterozygous:
Cell death resistance of leukocytes
References
  • Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis.;Tuzlak Selma, Haschka Manuel D, Mokina Anna-Maria, Rülicke Thomas, Cory Suzanne, Labi Verena, Villunger Andreas, ;2018;The FEBS journal;285;1403-1418; 29498802
Homozygous fertilenot known
Homozygous viablenot known
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreUniversity of Veterinary Medicine, Vienna, Austria
Animals used for archivingheterozygous C57BL/6N males

Literature references

  • Differential effects of Vav-promoter-driven overexpression of BCLX and BFL1 on lymphocyte survival and B cell lymphomagenesis.;Tuzlak Selma, Haschka Manuel D, Mokina Anna-Maria, Rülicke Thomas, Cory Suzanne, Labi Verena, Villunger Andreas, ;2018;The FEBS journal;285;1403-1418; 29498802

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
Distribution of this strain is subject to a provider MTA. Both signing of the MTA and submission of the online EMMA Mutant Request Form are required before material can be shipped.

EMMA conditions
Legally binding conditions for the transfer

Right strain for your research?

The information provided on this page is, to the best of EMMA’s knowledge, based on data supplied by the original provider. End users are responsible for reviewing these details and for validating the strain and its suitability for their experimental use.​
Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).